 "Natco in legal fight with FMC to produce CTPR based insecticide in India")
Generics pharmaceuticals company Natco Pharma Limited, which had recently established its Crop Health Sciences (CHS) division, on Monday informed that it has filed a suit for declaration of freedom to use Chlorantraniliprole(CTPR) at the city civil court here.
Natco is also awaiting regulatory approval for a product based on CTPR, which is a broad spectrum insecticide used in several crops.
CTPR is an active ingredient used in products commercialised by FMC under their brands Coragen and Ferterra. Following the Natco's action, FMC counter-sued the Hyderabad-based company in Delhi High Court claiming patent infringement.
Natco said it was hoping to bring formulations based on this product with affordability and accessibility to farmers across the country. The sales generated from CTPR containing products in India, inclusive of third-party marketing companies estimated to be Rs 1,540 crore in 2016, Natco said quoting a declaration filed by FMC.
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%